Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.9588
Abstract: Key Points Question Can widely available atrophy measures on magnetic resonance imaging (MRI) increase diagnostic accuracy of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD)? Findings In this diagnostic study of 326 participants, different methods… read more here.
Keywords: magnetic resonance; resonance imaging; progressive supranuclear; atrophy ... See more keywords
MDS criteria for the diagnosis of progressive supranuclear palsy overemphasize Richardson syndrome
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.51065
Abstract: MDS‐criteria for clinical diagnosis of progressive supranuclear palsy (PSP) were recently published, their usability in a classical clinical setting is yet unknown. We retrospectively applied the new criteria using PSP patients’ case files. Assignment of… read more here.
Keywords: mds criteria; diagnosis progressive; progressive supranuclear; supranuclear palsy ... See more keywords
Long‐Duration Progressive Supranuclear Palsy: Clinical Course and Pathological Underpinnings
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Neurology"
DOI: 10.1002/ana.26455
Abstract: To identify the clinical characteristics of the subgroup of benign progressive supranuclear palsy with particularly long disease duration; to define neuropathological determinants underlying variability in disease duration in progressive supranuclear palsy. read more here.
Keywords: progressive supranuclear; duration progressive; long duration; palsy clinical ... See more keywords
Real‐life benefits of intrajejunal levodopa infusion therapy in four patients with the parkinsonian variant of progressive supranuclear palsy: A 1‐year follow‐up data report
Sign Up to like & getrecommendations! Published in 2022 at "Brain and Behavior"
DOI: 10.1002/brb3.2547
Abstract: Progressive supranuclear palsy (PSP) is a progressive neurodegenerative condition presenting with different clinical endophenotypes. The parkinsonian variant of PSP (PSP‐P) is characterised by early but fading responsiveness to high‐dose levodopa therapy; however, high‐dose oral therapy… read more here.
Keywords: parkinsonian variant; real life; progressive supranuclear; therapy ... See more keywords
Clinical outcomes and cognitive impairments between progressive supranuclear palsy and multiple system atrophy
Sign Up to like & getrecommendations! Published in 2022 at "Brain and Behavior"
DOI: 10.1002/brb3.2827
Abstract: Both progressive supranuclear palsy (PSP) and multiple system atrophy (MSA) belong to atypical parkinsonian syndromes. It is important to differentiate these diseases accurately. We compared clinical outcomes and cognitive impairments between PSP and MSA. read more here.
Keywords: clinical outcomes; progressive supranuclear; multiple system; outcomes cognitive ... See more keywords
Weight loss in the early stage of progressive supranuclear palsy
Sign Up to like & getrecommendations! Published in 2017 at "Brain and Behavior"
DOI: 10.1002/brb3.616
Abstract: OBJECTIVES To clarify whether weight change in patients with Parkinson's disease (PD) or progressive supranuclear palsy (PSP) is caused by the disease itself or secondarily by other factors. MATERIALS AND METHODS We conducted a retrospective… read more here.
Keywords: supranuclear palsy; weight loss; early stage; stage ... See more keywords
Saccades in Progressive Supranuclear Palsy–Maladapted, Irregular, Curved, and Slow
Sign Up to like & getrecommendations! Published in 2017 at "Movement Disorders Clinical Practice"
DOI: 10.1002/mdc3.12491
Abstract: Slowed and curved rapid eye movements, saccades, are the well‐known features of progressive supranuclear palsy (PSP). The authors hypothesized that the saccades in PSP not only are slow and curved but also are irregular and… read more here.
Keywords: supranuclear palsy; palsy maladapted; maladapted irregular; saccades progressive ... See more keywords
Is it Useful to Classify Progressive Supranuclear Palsy and Corticobasal Degeneration as Different Disorders? No
Sign Up to like & getrecommendations! Published in 2018 at "Movement Disorders Clinical Practice"
DOI: 10.1002/mdc3.12582
Abstract: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2330-1619/homepage/mdc312582-sup-v001.htm. read more here.
Keywords: supranuclear palsy; useful classify; palsy corticobasal; classify progressive ... See more keywords
Clinicoradiological Features in Progressive Supranuclear Palsy Comorbid with Argyrophilic Grains
Sign Up to like & getrecommendations! Published in 2022 at "Movement Disorders Clinical Practice"
DOI: 10.1002/mdc3.13455
Abstract: Contrary to pure cases, the influence of comorbid argyrophilic grain disease (AGD) in progressive supranuclear palsy (PSP) has not been sufficiently evaluated. read more here.
Keywords: comorbid argyrophilic; progressive supranuclear; supranuclear palsy; clinicoradiological features ... See more keywords
Diagnostic Performance of Putaminal Hypointensity on Susceptibility MRI in Distinguishing Parkinson Disease from Progressive Supranuclear Palsy: A Meta‐Analysis
Sign Up to like & getrecommendations! Published in 2022 at "Movement Disorders Clinical Practice"
DOI: 10.1002/mdc3.13573
Abstract: Idiopathic Parkinson's disease (IPD) and progressive supranuclear palsy (PSP) have similar clinical signs and symptoms, making accurate clinical diagnosis difficult. T2* gradient echo (T2* GRE), susceptibility‐weighted imaging (SWI), and quantitative susceptibility mapping (QSM) are susceptibility… read more here.
Keywords: progressive supranuclear; susceptibility; parkinson disease; supranuclear palsy ... See more keywords
Longitudinal magnetic resonance imaging in progressive supranuclear palsy: A new combined score for clinical trials
Sign Up to like & getrecommendations! Published in 2017 at "Movement Disorders"
DOI: 10.1002/mds.26973
Abstract: Two recent, randomized, placebo‐controlled phase II/III trials (clinicaltrials.gov: NCT01110720, NCT01049399) of davunetide and tideglusib in progressive supranuclear palsy (PSP) generated prospective, 1‐year longitudinal datasets of high‐resolution T1‐weighted three‐dimensional MRI. read more here.
Keywords: longitudinal magnetic; resonance imaging; supranuclear palsy; magnetic resonance ... See more keywords